Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High Risk Patients

Format: Webinar
Credit(s): 1.00 (60 min)
Webinar Date(s):
9/23/2021 8:30 PM - 9:30 PM ET
9/27/2021 - 8:00 - 9:00 PM ET
9/28/2021 - 7:00 - 8:00 PM ET
Credit Type(s):
  • Physicians – AMA PRA Category 1 Credit(s) ™
  • Physicians/ABIM MOC – ABIM MOC Point(s)
  • Physicians/ABD MOC – ABD MOC Point(s)

PROGRAM OVERVIEW

This activity, Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High-Risk Patients, will review emerging trends in diagnosis and risk stratification for patients with common skin cancers, including melanoma and cSCC, including discussion of current diagnostic strategies, challenges in risk stratification, and clinical applications for new molecular tests designed to identify high-risk patients and aid in treatment decision-making.

RELATED COURSES

Managing Advanced Prostate Cancer in the COVID-19 Era: What Do Oncologists Need to Know?

Learn More

Advancements in First-Line Therapeutics for NSCLC: Navigation of Current Treatment Options for Stage IV Non-Squamous NSCLC

Learn More

Current Issues In Breast Cancer Management: HER2 Low Expression

Learn More
This entry was posted in . Bookmark the permalink.

Follow Us :

Follow Us :

© 2021 Rockpointe Corporation

Privacy Policy

© 2021 Rockpointe Corporation

Privacy Policy